These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11373784)

  • 1. [Determining resistance in HIV therapy. Careful interpretation only].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():54-5. PubMed ID: 11373784
    [No Abstract]   [Full Text] [Related]  

  • 2. A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience.
    Schooley RT; Clumeck N; Haubrich R; Thompson M; Danner SA; van Der Ende ME; Sereni D; Antunes F; Blake D; Myers RE; Tisdale M; Millard J; Mustafa N; Nacci P
    Antivir Ther; 2001 Jun; 6(2):89-96. PubMed ID: 11491421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amprenavir (Agenerase).
    Res Initiat Treat Action; 2000 Mar; 6(1):32-3. PubMed ID: 11708186
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV and drug resistance - interpretation and therapeutic progress.
    Gürtler L
    Intervirology; 2012; 55(2):77-8. PubMed ID: 22286873
    [No Abstract]   [Full Text] [Related]  

  • 5. Drifting agenda for federal treatment research.
    Huff B
    GMHC Treat Issues; 2001 May; 15(5):1-4. PubMed ID: 11548299
    [No Abstract]   [Full Text] [Related]  

  • 6. [New variations in highly active antiretroviral therapy. Simple combination as a promising option].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():50-2. PubMed ID: 10863312
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
    Lang S; Mary-Krause M; Cotte L; Gilquin J; Partisani M; Simon A; Boccara F; Costagliola D;
    Arch Intern Med; 2010 Jul; 170(14):1228-38. PubMed ID: 20660842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amping amprenavir with ritonavir.
    TreatmentUpdate; 2001; 12(12):10. PubMed ID: 11570075
    [No Abstract]   [Full Text] [Related]  

  • 9. [Safety in routine clinical practice. Hypersensitivity can be managed].
    MMW Fortschr Med; 2000; 142(3 Suppl):22-3. PubMed ID: 10893956
    [No Abstract]   [Full Text] [Related]  

  • 10. Abacavir (Ziagen).
    Res Initiat Treat Action; 2000 Mar; 6(1):16-7. PubMed ID: 11708178
    [No Abstract]   [Full Text] [Related]  

  • 11. [HIV mutant M184V. Benefits of a mutation].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():53-4. PubMed ID: 11373783
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV drug resistance testing: an update for the clinician.
    Rice HL; Zolopa AR
    AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921
    [No Abstract]   [Full Text] [Related]  

  • 13. Viral patterns of unboosted 908 identified.
    AIDS Patient Care STDS; 2003 Aug; 17(8):431. PubMed ID: 13678545
    [No Abstract]   [Full Text] [Related]  

  • 14. [Highly active antiretroviral therapy. A simple combination, but high effectiveness].
    MMW Fortschr Med; 2000; 142(3 Suppl):20-2. PubMed ID: 10893955
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance investigations during HIV-therapy is necessary].
    Schattenfroh S
    Dtsch Med Wochenschr; 1998 Feb; 123(7):A7. PubMed ID: 9505940
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV drug resistance testing: data be damned.
    Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172
    [No Abstract]   [Full Text] [Related]  

  • 17. Glaxo Wellcome's two new drugs.
    Res Initiat Treat Action; 1998 Dec; 4(7):14. PubMed ID: 11366081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drugs: amprenavir and abacavir.
    TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral resistance: a major challenge in managing HIV disease.
    Boucher CA; Reedijk M
    J Biol Regul Homeost Agents; 1995; 9(3):91-4. PubMed ID: 8782014
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.